4.7 Review

Complement in Human Brain Health: Potential of Dietary Food in Relation to Neurodegenerative Diseases

Related references

Note: Only part of the references are listed.
Article Food Science & Technology

Kaempferol prevents the activation of complement C3 protein and the generation of reactive A1 astrocytes that mediate rat brain degeneration induced by 3-nitropropionic acid

Carmen Lopez-Sanchez et al.

Summary: The study demonstrates that kaempferol protects against the activation of complement C3 protein and the generation of reactive A1 astrocytes in the striatum and hippocampus. Additionally, it blocks the increased expression of NF-kappa B and enhances the secretion of cytokines IL-1 alpha, TNF alpha, and C1q, while also preventing the production of amyloid beta peptides.

FOOD AND CHEMICAL TOXICOLOGY (2022)

Article Neurosciences

Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy

A. Harrison Brody et al.

Summary: The presence of Pyk2 protein affects the phosphorylation of Tau protein and the activity of protein kinases, which in turn influences Alzheimer's disease. The absence of Pyk2 exacerbates pathological features related to Tau in mouse models.

MOLECULAR NEURODEGENERATION (2022)

Review Biochemistry & Molecular Biology

Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis

Swapna Thomas et al.

Summary: Antibody-dependent enhancement (ADE) refers to the phenomenon where antibody response to a viral infection exacerbates the severity of the disease. Studies have shown that antibodies against SARS-CoV and MERS-CoV can enhance infection via ADE. Recent research also suggests a risk of disease severity via ADE in SARS-CoV-2. ADE occurs partially due to non-neutralizing or sub-neutralizing antibodies, which result in the deposition of antigen-antibody complexes and chronic inflammatory processes that damage affected tissues.

MOLECULAR IMMUNOLOGY (2022)

Article Biology

Black Ginseng Ameliorates Cellular Senescence via p53-p21/p16 Pathway in Aged Mice

Su-Jeong Lee et al.

Summary: This study examined the impact of black ginseng (BG) on cellular senescence and found that BG supplementation can delay cellular senescence, particularly reducing activation of the canonical senescence pathway in multiple metabolic organs. The findings suggest that BG may be a potential senolytic candidate for retarding the aging process.

BIOLOGY-BASEL (2022)

Review Immunology

Complement C1s as a diagnostic marker and therapeutic target: Progress and propective

Jun Ye et al.

Summary: This article introduces the important role of C1s as a molecule in the complement system, its association with the development and diagnosis of various diseases, and summarizes the progress in developing drugs targeting C1s.

FRONTIERS IN IMMUNOLOGY (2022)

Article Clinical Neurology

Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice

Mickael Audrain et al.

Summary: The research shows that TYROBP-APOE signaling does not require TREM2 and may be an initiating step in establishing the disease-associated microglia (DAM) phenotype.

ALZHEIMERS & DEMENTIA (2021)

Article Cell Biology

Microglia Polarization from M1 toward M2 Phenotype Is Promoted by Astragalus Polysaccharides Mediated through Inhibition of miR-155 in Experimental Autoimmune Encephalomyelitis

Xiaojun Liu et al.

Summary: The study found that Astragalus polysaccharides (APS) can effectively treat central nervous system demyelinating diseases by regulating the polarization of microglia from M1 to M2 phenotype through inhibiting miR-155, reducing the secretion of inflammatory factors, and inhibiting the activation of neurotoxic astrocytes.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Clinical Neurology

Challenges in the diagnosis of Parkinson's disease

Eduardo Tolosa et al.

Summary: Parkinson's disease is the second most common neurodegenerative disease, with efforts being made to accurately diagnose and characterize it, including validation of diagnostic criteria and identification of genetic subtypes. Progress in diagnostic biomarkers has opened up possibilities for earlier identification, recognition of diverse subtypes, and development of novel treatments.

LANCET NEUROLOGY (2021)

Article Neurosciences

Cholecystokinin octapeptide improves hippocampal glutamatergic synaptogenesis and postoperative cognition by inhibiting induction of A1 reactive astrocytes in aged mice

Lei Chen et al.

Summary: The study showed that CCK-8 alleviates cognitive impairment and promotes glutamatergic synaptogenesis by inhibiting the induction of A1 reactive astrocytes and the activation of microglia, suggesting it as a potential therapeutic target for dNCR.

CNS NEUROSCIENCE & THERAPEUTICS (2021)

Article Multidisciplinary Sciences

Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury

Stephanie S. Holden et al.

Summary: Traumatic brain injury (TBI) can acutely damage the cortex, but most disabilities associated with TBI are due to secondary injuries that accumulate over time, with the thalamus potentially being a key site. Research in a mouse model of mild TBI (mTBI) revealed chronic elevation of C1q in the corticothalamic system, correlating with neuron loss, chronic inflammation, disrupted sleep spindles, and emergence of epileptic activities. Blocking C1q may counteract these effects, suggesting it as a potential disease modifier in mTBI, with microglia identified as a source of thalamic C1q. Targeting the corticothalamic circuit could offer new avenues for treating TBI-related disabilities.

SCIENCE (2021)

Review Immunology

The Role of Complement in Synaptic Pruning and Neurodegeneration

Angela Gomez-Arboledas et al.

Summary: The complement system is essential for brain function, but inappropriate activation can lead to inflammation; Initial components C1q and C-3 play key roles in synaptic refinement, but excessive pruning may be harmful.

IMMUNOTARGETS AND THERAPY (2021)

Review Neurosciences

Immune cell regulation of glia during CNS injury and disease

Andrew D. Greenhalgh et al.

NATURE REVIEWS NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Early Reactive A1 Astrocytes Induction by the Neurotoxin 3-Nitropropionic Acid in Rat Brain

Carmen Lopez-Sanchez et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Immunology

The good, the bad, and the opportunities of the complement system in neurodegenerative disease

Nicole D. Schartz et al.

JOURNAL OF NEUROINFLAMMATION (2020)

Article Biochemistry & Molecular Biology

ApoE attenuates unresolvable inflammation by complex formation with activated C1q

Changjun Yin et al.

NATURE MEDICINE (2019)

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

Review Medicine, General & Internal

Parkinson's Disease and Parkinsonism

Michael T. Hayes

AMERICAN JOURNAL OF MEDICINE (2019)

Article Medicine, Research & Experimental

Cigarette smoke induced reduction of C1q promotes emphysema

Xiaoyi Yuan et al.

JCI INSIGHT (2019)

Review Clinical Neurology

Huntington's disease: a clinical review

P. McColgan et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Biochemistry & Molecular Biology

New tricks for an ancient system: Physiological and pathological roles of complement in the CNS

Andrea J. Tenner et al.

MOLECULAR IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Normal aging induces A1-like astrocyte reactivity

Laura E. Clarke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Local apoptotic-like mechanisms underlie complement mediated synaptic pruning

Balazs A. Gyorffy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism

Guang Sheng Ling et al.

SCIENCE (2018)

Article Biochemistry & Molecular Biology

Traumatic Brain Injury in Aged Mice Induces Chronic Microglia Activation, Synapse Loss, and Complement-Dependent Memory Deficits

Karen Krukowski et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Cell Biology

Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics

Matthew L. Pearn et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)

Article Pharmacology & Pharmacy

Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases

Janice A. Lansita et al.

INTERNATIONAL JOURNAL OF TOXICOLOGY (2017)

Article Immunology

Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain

Maria I. Fonseca et al.

JOURNAL OF NEUROINFLAMMATION (2017)

Review Biochemistry & Molecular Biology

C1q as an autocrine and paracrine regulator of cellular functions

Berhane Ghebrehiwet et al.

MOLECULAR IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

Neurotoxic reactive astrocytes are induced by activated microglia

Shane A. Liddelow et al.

NATURE (2017)

Article Clinical Neurology

Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network

Hideyuki Takahashi et al.

ACTA NEUROPATHOLOGICA (2017)

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

Article Immunology

Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling

Robert Kolm et al.

JOURNAL OF IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Soyon Hong et al.

SCIENCE (2016)

Article Multidisciplinary Sciences

Apoptosis signal-regulating kinase 1 mediates striatal degeneration via the regulation of C1q

Kyoung Joo Cho et al.

SCIENTIFIC REPORTS (2016)

Article Immunology

Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency

Rosanne A. van Schaarenburg et al.

JOURNAL OF AUTOIMMUNITY (2015)

Review Biochemistry & Molecular Biology

C1q, antibodies and anti-C1q autoantibodies

Frank J. Beurskens et al.

MOLECULAR IMMUNOLOGY (2015)

Review Immunology

Microglia: Dynamic Mediators of Synapse Development and Plasticity

Yuwen Wu et al.

TRENDS IN IMMUNOLOGY (2015)

Review Immunology

The choreography of neuroinflammation in Huntington's disease

Andrea Crotti et al.

TRENDS IN IMMUNOLOGY (2015)

Article Immunology

Relative Contribution of C1q and Aopototic Cell-Surface Calreticulin to Macrophage Phagocytosis

Melanie Verneret et al.

JOURNAL OF INNATE IMMUNITY (2014)

Article Neurosciences

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis

Gillian Ingram et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Review Cell Biology

From development to dysfunction: Microglia and the complement cascade in CNS homeostasis

Matthew K. Zabel et al.

AGEING RESEARCH REVIEWS (2013)

Article Neurosciences

A Dramatic Increase of C1q Protein in the CNS during Normal Aging

Alexander H. Stephan et al.

JOURNAL OF NEUROSCIENCE (2013)

Article Biochemistry & Molecular Biology

Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes

Atsuhiko T. Naito et al.

Article Agriculture, Multidisciplinary

Anthocyanin-rich Acai (Euterpe oleracea Mart.) Fruit Pulp Fractions Attenuate Inflammatory Stress Signaling in Mouse Brain BV-2 Microglial Cells

Shibu M. Poulose et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Human and Pneumococcal Cell Surface Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Proteins Are Both Ligands of Human C1q Protein

Remi Terrasse et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Review Immunology

The human C1q globular domain: structure and recognition of non-immune self ligands

Christine Gaboriaud et al.

FRONTIERS IN IMMUNOLOGY (2012)

Article Biochemistry & Molecular Biology

Heme Interacts with C1q and Inhibits the Classical Complement Pathway

Lubka T. Roumenina et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Investigations on the C1q-Calreticulin-Phosphatidylserine Interactions Yield New Insights into Apoptotic Cell Recognition

Helena Paidassi et al.

JOURNAL OF MOLECULAR BIOLOGY (2011)

Article Clinical Neurology

Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease

Candan Depboylu et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)

Review Clinical Neurology

Astrocytes: biology and pathology

Michael V. Sofroniew et al.

ACTA NEUROPATHOLOGICA (2010)

Review Neurosciences

Astrocyte heterogeneity: an underappreciated topic in neurobiology

Ye Zhang et al.

CURRENT OPINION IN NEUROBIOLOGY (2010)

Article Multidisciplinary Sciences

Enhanced synaptic connectivity and epilepsy in C1q knockout mice

Yunxiang Chu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Adiponectin binds C1q and activates the classical pathway of complement

Philip W. Peake et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Biochemistry & Molecular Biology

Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide

Lubka T. Roumenina et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)

Article Biochemistry & Molecular Biology

The classical complement cascade mediates CNS synapse elimination

Beth Stevens et al.

Article Medicine, Research & Experimental

Suppressive effects of melatonin on amyloid-β-induced glial activation in rat hippocampus

Yuxian Shen et al.

ARCHIVES OF MEDICAL RESEARCH (2007)

Article Immunology

C1q and its growing family

Rohit Ghai et al.

IMMUNOBIOLOGY (2007)

Article Immunology

Assembly of C1 and the MBL- and ficolin-MASP complexes: Structural insights

Christine Gaboriaud et al.

IMMUNOBIOLOGY (2007)

Review Geriatrics & Gerontology

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment

Stephen W. Scheff et al.

NEUROBIOLOGY OF AGING (2006)

Article Hematology

Blood platelets activate the classical pathway of human complement

E. I. B. Peerschke et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Article Biochemistry & Molecular Biology

The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties

C Gaboriaud et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Immunology

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q

AJ Nauta et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2003)

Article Immunology

C1q, autoimmunity and apoptosis

M Botto et al.

IMMUNOBIOLOGY (2002)

Article Critical Care Medicine

Complement activation in the human brain after traumatic head injury

BM Bellander et al.

JOURNAL OF NEUROTRAUMA (2001)

Review Medicine, General & Internal

Advances in immunology: Complement (First of two parts).

MJ Walport

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Clinical Neurology

Activated microglial cells and complement factors are unrelated to cortical Lewy bodies

AJM Rozemuller et al.

ACTA NEUROPATHOLOGICA (2000)

Review Immunology

Clq receptors

P Eggleton et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)